<DOC>
	<DOC>NCT00398476</DOC>
	<brief_summary>The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.</brief_summary>
	<brief_title>Fluticasone Nasal Spray Patient Preference Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>allergic rhinitis literate clinical significant uncontrolled disease Use of intranasal corticosteroids (&lt;4 weeks of FP [branded or generic],&lt;4 week exposure to FF, &lt;4 weeks use of other INS) Use of intranasal medications &lt;1 week Use of meds that significantly inhibit CYP4503A4 Use of perfume or oral rinse on study day Allergy/intolerance to INS, antihistamines, or excipients Positive pregnancy test or female who is breastfeeding Affiliation with investigational site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>taste</keyword>
	<keyword>questionnaire</keyword>
	<keyword>preference</keyword>
	<keyword>attributes</keyword>
	<keyword>odor</keyword>
	<keyword>after taste</keyword>
	<keyword>scent</keyword>
</DOC>